For citations:
Advisory Board conclusion following the discussion "Controversial issues of low molecular weight heparins use in obstetrics". Obstetrics, Gynecology and Reproduction. 2021;15(4):461-469. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2021.244
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
